Medicare Enrolled

Dr. Alan Koletsky, MD

Optician · Delray Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
6282 LINTON BLVD, Delray Beach, FL 33484
5614958307
In practice since 2006 (19 years)
NPI: 1952359234 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Koletsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koletsky? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Koletsky

Dr. Alan Koletsky is an optician in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Koletsky performed 243 Medicare services across 156 unique beneficiaries.

Between the years covered by Open Payments, Dr. Koletsky received a total of $43,209 from 58 pharmaceutical and/or device companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Koletsky is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 243 Medicare services$ $43,209 industry payments

Medicare Practice Summary

Medicare Utilization ↗
243
Medicare services
Bottom 16% in FL for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
156
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)144$71$260
Office visit, established patient (20-29 min)99$51$186
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$43,209
Total received (2018-2023)
Avg $7,202/year across 6 years
Top 5% in FL for optician
58
Companies
381
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20,363 (47.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,426 (31.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,419 (21.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$884
2022
$3,571
2021
$6,715
2020
$3,808
2019
$3,950
2018
$24,281

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Exelixis Inc.
$13,335
GENZYME CORPORATION
$6,425
E.R. Squibb & Sons, L.L.C.
$4,688
Bayer HealthCare Pharmaceuticals Inc.
$3,309
Astellas Pharma Global Development
$2,241
PFIZER INC.
$1,986
Seagen Inc.
$1,731
Pfizer Inc.
$1,600
Aveo Pharmaceuticals, Inc.
$1,077
Hoffmann-La Roche Limited
$946
Janssen Biotech, Inc.
$930
Sirtex Medical Inc
$593
AstraZeneca Pharmaceuticals LP
$462
Merck Sharp & Dohme Corporation
$456
Genentech USA, Inc.
$438
Astellas Pharma US Inc
$342
Novartis Pharmaceuticals Corporation
$274
Boehringer Ingelheim Pharmaceuticals, Inc.
$254
Celgene Corporation
$199
Lilly USA, LLC
$163
Eisai Inc.
$162
JAZZ PHARMACEUTICALS INC.
$153
Amgen Inc.
$135
Puma Biotechnology, Inc.
$130
Merck Sharp & Dohme LLC
$80
Deciphera Pharmaceuticals Inc.
$73
AVEO Pharmaceuticals, Inc.
$59
NOVARTIS PHARMACEUTICALS CORPORATION
$59
Ipsen Biopharmaceuticals, Inc
$56
Incyte Corporation
$52
Blue Earth Diagnostics Limited
$50
Mirati Therapeutics, Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$45
Taiho Oncology, Inc.
$41
AMAG Pharmaceuticals, Inc.
$40
EMD Serono, Inc.
$40
Pharmacyclics LLC, An AbbVie Company
$40
EISAI INC.
$39
TerSera Therapeutics LLC
$38
AbbVie, Inc.
$35
INSYS Therapeutics Inc
$34
MEDIVATION FIELD SOLUTIONS LLC
$30
Spectrum Pharmaceuticals Inc.
$30
Dova Pharmaceuticals
$28
Pharmacyclics LLC, an AbbVie Company
$27
Foundation Medicine, Inc.
$26
Agios Pharmaceuticals, Inc.
$23
SOBI, INC
$21
ABBVIE INC.
$21
BeiGene USA, Inc.
$21
ARRAY BIOPHARMA INC
$20
Karyopharm Therapeutics Inc.
$18
Sobi, Inc
$17
Jazz Pharmaceuticals Inc.
$17
AbbVie Inc.
$14
Aurobindo Pharma USA, Inc.
$14
TESARO, Inc.
$14
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 56.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · Alecensa · Avastin · Axumin · BAVENCIO · BENDEKA · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · ERBITUX · ERLEADA · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · Folotyn · GILOTRIF · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MYLOTARG · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OPDIVO · PADCEV · PIQRAY · PROMACTA · Padcev · QINLOCK · REBLOZYL · Revlimid · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUBSYS · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · VENCLEXTA · VYXEOS · Venclexta · XALKORI · XOSPATA · XPOVIO · XTANDI · Xofigo · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (47%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for optician in FL.

Equivalent to $17,781 per 100 Medicare services performed
Looking for a optician in Delray Beach?
Compare opticians in the Delray Beach area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
495
Per 100K population
32.8
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Koletsky is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 5%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Koletsky experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Koletsky performed 144 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Koletsky receive payments from pharmaceutical companies?
Yes. Dr. Koletsky received a total of $43,209 from 58 companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koletsky's costs compare to other opticians in Delray Beach?
Dr. Koletsky's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koletsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →